<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD07160000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>O14745</UniProt_ID>
  <Seq_Length>358</Seq_Length>
  <Molecule_Weight>38868</Molecule_Weight>
  <KEGG_ID>hsa:9368</KEGG_ID>
  <Orthology_ID>K13365</Orthology_ID>
  <EBI_ID>EBI-349787</EBI_ID>
  <Function_Summary>Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for recycling of internalized ADRB2. Was first known to play a role in the regulation of the activity and subcellular location of SLC9A3. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May enhance Wnt signaling. May participate in HTR4 targeting to microvilli (By similarity). Involved in the regulation of phosphate reabsorption in the renal proximal tubules.</Function_Summary>
  <Pfam_ID>PF09007:EBP50_C-term@@PF00595:PDZ</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>NHERF-1</Alias>
      <Alias>Sodium-hydrogen exchanger regulatory factor 1</Alias>
      <Alias>EBP50</Alias>
      <Alias>Ezrin-radixin-moesin-binding phosphoprotein 50</Alias>
      <Alias>Regulatory cofactor of Na(+)/H(+) exchanger</Alias>
      <Alias>Solute carrier family 9 isoform A3 regulatory factor 1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a beta-2 adrenergic receptor.</Detail>
      <Keyword>Beta-2 adrenergic receptor binding</Keyword>
      <Ontology_ID>GO:0031698</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the beta subunit of the catenin complex.</Detail>
      <Keyword>Beta-catenin binding</Keyword>
      <Ontology_ID>GO:0008013</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively with a growth factor receptor.</Detail>
      <Keyword>Growth factor receptor binding</Keyword>
      <Ontology_ID>GO:0070851</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.</Detail>
      <Keyword>PDZ domain binding</Keyword>
      <Ontology_ID>GO:0030165</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a domain within the same polypeptide.</Detail>
      <Keyword>Protein self-association</Keyword>
      <Ontology_ID>GO:0043621</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Modulates the activity of a chloride channel.</Detail>
      <Keyword>Chloride channel regulator activity</Keyword>
      <Ontology_ID>GO:0017081</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any phosphatase.</Detail>
      <Keyword>Phosphatase binding</Keyword>
      <Ontology_ID>GO:0019902</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>153</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.</Detail>
      <Keyword>Negative regulation of phosphatidylinositol 3-kinase cascade</Keyword>
      <Ontology_ID>GO:0014067</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of cell proliferation.</Detail>
      <Keyword>Negative regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008285</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the protein kinase B signaling cascade, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.</Detail>
      <Keyword>Negative regulation of protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0051898</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated release of bile acid, composed of any of a group of steroid carboxylic acids occurring in bile, by a cell or group of cells.</Detail>
      <Keyword>Bile acid secretion</Keyword>
      <Ontology_ID>GO:0032782</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of protein kinase activity.</Detail>
      <Keyword>Regulation of protein kinase activity</Keyword>
      <Ontology_ID>GO:0045859</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.</Detail>
      <Keyword>Negative regulation of platelet-derived growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0010642</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The aggregation, arrangement and bonding together of a set of components to form a protein complex.</Detail>
      <Keyword>Protein complex assembly</Keyword>
      <Ontology_ID>GO:0006461</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Formation of a microvillus, a thin cylindrical membrane-covered projection on the surface of a cell.</Detail>
      <Keyword>Microvillus assembly</Keyword>
      <Ontology_ID>GO:0030033</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of glutathione, the tripeptide glutamylcysteinylglycine, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Glutathione transport</Keyword>
      <Ontology_ID>GO:0034635</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Negative regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070373</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.</Detail>
      <Keyword>Wnt receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0016055</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A renal system process in which water, ions, and glucose are taken up from the collecting ducts and proximal and distal loops of the nephron.</Detail>
      <Keyword>Renal absorption</Keyword>
      <Ontology_ID>GO:0070293</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>46</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>280</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>294</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>288</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>302</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>290</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>293</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>291</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL</Protein_Seq>
    <DNA_Seq>GGACTCTGGGACGCTCAGACGCCGCGCGGGGCGGGGATTGGTCTGTGGTCCTCTCTCGGCTCCTCGCGGCTCGCGGCGGCCGACGGTTCCTGGGACACCTGCTTGCTTGGCCCGTCCGGCGGCTCAGGGCTTCTCTGCTGCGCTCCCGGTTCGCTGGACGGGAAGAAGGGCTGGGCCGTCCCGTCCCGTCCCCATCGGAACCCCAAGTCGCGCCGCTGACCCGTCGCAGGGCGAGATGAGCGCGGACGCAGCGGCCGGGGCGCCCCTGCCCCGGCTCTGCTGCCTGGAGAAGGGTCCGAACGGCTACGGCTTCCACCTGCACGGGGAGAAGGGCAAGTTGGGCCAGTACATCCGGCTGGTGGAGCCCGGCTCGCCGGCCGAGAAGGCGGGGCTGCTGGCGGGGGACCGGCTGGTGGAGGTGAACGGCGAAAACGTGGAGAAGGAGACCCACCAGCAGGTGGTGAGCCGCATCCGCGCCGCACTCAACGCCGTGCGCCTGCTGGTGGTCGACCCCGAGACGGACGAGCAGCTGCAGAAGCTCGGCGTCCAGGTCCGAGAGGAGCTGCTGCGCGCCCAGGAAGCGCCGGGGCAGGCCGAGCCGCCGGCCGCCGCCGAGGTGCAGGGGGCTGGCAACGAAAATGAGCCTCGCGAGGCCGACAAGAGCCACCCGGAGCAGCGCGAGCTTCGGCCTCGGCTCTGTACCATGAAGAAGGGCCCCAGTGGCTATGGCTTCAACCTGCACAGCGACAAGTCCAAGCCAGGCCAGTTCATCCGGTCAGTGGACCCAGACTCCCCGGCTGAGGCTTCAGGGCTCCGGGCCCAGGATCGCATTGTGGAGGTGAACGGGGTCTGCATGGAGGGGAAGCAGCATGGGGACGTGGTGTCCGCCATCAGGGCTGGCGGGGACGAGACCAAGCTGCTGGTGGTGGACAGGGAAACTGACGAGTTCTTCAAGAAATGCAGAGTGATCCCATCTCAGGAGCACCTGAATGGTCCCCTGCCTGTGCCCTTCACCAATGGGGAGATACAGAAGGAGAACAGTCGTGAAGCCCTGGCAGAGGCAGCCTTGGAGAGCCCCAGGCCAGCCCTGGTGAGATCCGCCTCCAGTGACACCAGCGAGGAGCTGAATTCCCAAGACAGCCCCCCAAAACAGGACTCCACAGCGCCCTCGTCTACCTCCTCCTCCGACCCCATCCTAGACTTCAACATCTCCCTGGCCATGGCCAAAGAGAGGGCCCACCAGAAACGCAGCAGCAAACGGGCCCCGCAGATGGACTGGAGCAAGAAAAACGAACTCTTCAGCAACCTCTGAGCGCCCTGCTGCCACCCAGTGACTGGCAGGGCCGAGCCAGCATTCCACCCCACCTTTTTCCTTCTCCCCAATTACTCCCCTGAATCAATGTACAAATCAGCACCCACATCCCCTTTCTTGACAAATGATTTTTCTAGAGAACTATGTTCTTCCCTGACTTTAGGGAAGGTGAATGTGTTCCCGTCCTCCCGCAGTCAGAAAGGAGACTCTGCCTCCCTCCTCCTCACTGAGTGCCTCATCCTACCGGGTGTCCCTTTGCCACCCTGCCTGGGACATCGCTGGAACCTGCACCATGCCAGGATCATGGGACCAGGCGAGAGGGCACCCTCCCTTCCTCCCCCATGTGATAAATGGGTCCAGGGCTGATCAAAGAACTCTGACTGCAGAACTGCCGCTCTCAGTGGACAGGGCATCTGTTACCCTGAGACCTGTGGCAGACACGTCTTGTTTTCATTTGATTTTTGTTAAGAGTGCAGTATTGCAGAGTCTAGAGGAATTTTTGTTTCCTTGATTAACATGATTTTCCTGGTTGTTACATCCAGGGCATGGCAGTGGCCTCAGCCTTAAACTTTTGTTCCTACTCCCACCCTCAGCGAACTGGGCAGCACGGGGAGGGTTTGGCTACCCCTGCCCATCCCTGAGCCAGGTACCACCATTGTAAGGAAACACTTTCAGAAATTCAGCTGGTTCCTCCAAACCCTTCAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Pancreas</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Placenta</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Prostate</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Syncytiotrophoblast</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Small intestine</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Kidney</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Intracellular membrane-bounded organelle</CellLocal>
      <Ontology_ID>GO:0043231</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Apical plasma membrane</CellLocal>
      <Ontology_ID>GO:0016324</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Filopodium</CellLocal>
      <Ontology_ID>GO:0030175</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell projection</CellLocal>
      <Ontology_ID>GO:0042995</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Centrosome</CellLocal>
      <Ontology_ID>GO:0005813</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microvillus membrane</CellLocal>
      <Ontology_ID>GO:0031528</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Actin cytoskeleton</CellLocal>
      <Ontology_ID>GO:0015629</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Apical cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endomembrane system</CellLocal>
      <Ontology_ID>GO:0012505</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Ruffle</CellLocal>
      <Ontology_ID>GO:0001726</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>SLC9A3R1</Gene_Name>
    <Gene_Alias>NHERF; NHERF1</Gene_Alias>
    <Gene_ID>9368</Gene_ID>
    <Genbank_ACCN>NM_004252</Genbank_ACCN>
    <Protein_ACCN>NP_004243</Protein_ACCN>
    <HGNC_ID>11075</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/9368</Gene_URL>
    <UCSC_ID>uc002jlo.3</UCSC_ID>
    <EMBL_ID>ENSG00000109062</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P35240-1</Uniprot_ID>
      <Gene_Name>NF2</Gene_Name>
      <EBI_ID>EBI-1014500</EBI_ID>
      <PPI_EBI_URL>EBI-349787,EBI-1014500</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P13569</Uniprot_ID>
      <Gene_Name>CFTR</Gene_Name>
      <EBI_ID>EBI-349854</EBI_ID>
      <PPI_EBI_URL>EBI-349787,EBI-349854</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P26038</Uniprot_ID>
      <Gene_Name>MSN</Gene_Name>
      <EBI_ID>EBI-528768</EBI_ID>
      <PPI_EBI_URL>EBI-349787,EBI-528768</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Nephrolithiasis/osteoporosis, Hypophosphatemic, 2</Disease_Name>
      <Disease_Detail>Nephrolithiasis</Disease_Detail>
      <Disease_DB>NPH042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrolithiasis_osteoporosis_hypophosphatemic_2?search=SLC9A3R1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteoporosis</Disease_Name>
      <Disease_Detail>Osteoporosis</Disease_Detail>
      <Disease_DB>OST002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteoporosis?search=SLC9A3R1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cystic Fibrosis</Disease_Name>
      <Disease_Detail>Cystic Fibrosis</Disease_Detail>
      <Disease_DB>CYS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cystic_fibrosis?search=SLC9A3R1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nephrolithiasis</Disease_Name>
      <Disease_Detail>Nephrolithiasis</Disease_Detail>
      <Disease_DB>NPH009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrolithiasis?search=SLC9A3R1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypophosphatemic Nephrolithiasis/osteoporosis, 1</Disease_Name>
      <Disease_Detail>Hypophosphatemic Nephrolithiasis/osteoporosis, 1</Disease_Detail>
      <Disease_DB>HYP258</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypophosphatemic_nephrolithiasis_osteoporosis_1?search=SLC9A3R1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=SLC9A3R1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>The crystal structure of the 2nd PDZ domain of the human NHERF-1 (SLC9A3R1)</PDB_Title>
      <PDB_ID>2OZF</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OZF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The crystal structure of the 2nd PDZ domain of the human NHERF-1 (SLC9A3R1)</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURAL DETERMINANTS OF THE NHERF INTERACTION WITH BETA2-AR AND PDGFR</PDB_Title>
      <PDB_ID>1GQ5</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GQ5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Determinants of the Na+/H+ Exchanger Regulatory Factor Interaction with the Beta 2 Adrenergic and Platelet-Derived Growth Factor Receptors</PubMed_Title>
      <Author>Karthikeyan, S., et al.</Author>
      <Journal>J.Biol.Chem.(2002)277:18973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11882663?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURAL DETERMINANTS OF THE NHERF INTERACTION WITH BETA2AR AND PDGFR</PDB_Title>
      <PDB_ID>1GQ4</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GQ4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Determinants of the Na+/H+ Exchanger Regulatory Factor Interaction with the Beta 2 Adrenergic and Platelet-Derived Growth Factor Receptors</PubMed_Title>
      <Author>Karthikeyan, S., et al.</Author>
      <Journal>J.Biol.Chem.(2002)277:18973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11882663?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURAL BASIS OF THE NHERF PDZ1-CFTR INTERACTION</PDB_Title>
      <PDB_ID>1I92</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1I92</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of the Na+/H+ exchanger regulatory factor PDZ1 interaction with the carboxyl-terminal region of the cystic fibrosis transmembrane conductance regulator.</PubMed_Title>
      <Author>Karthikeyan, S., et al.</Author>
      <Journal>J.Biol.Chem.(2001)276:19683-19686</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11304524?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Moesin FERM domain bound to EBP50 C-terminal peptide</PDB_Title>
      <PDB_ID>1SGH</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SGH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The EBP50-moesin interaction involves a binding site regulated by direct masking on the FERM domain</PubMed_Title>
      <Author>Finnerty, C.M., et al.</Author>
      <Journal>J.Cell.Sci.(2004)117:1547-1552</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15020681?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FIRST PDZ DOMAIN OF THE HUMAN NA+/H+ EXCHANGER REGULATORY FACTOR</PDB_Title>
      <PDB_ID>1G9O</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1G9O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the PDZ1 domain of human Na(+)/H(+) exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class I PDZ domains.</PubMed_Title>
      <Author>Karthikeyan, S., et al.</Author>
      <Journal>J.Mol.Biol.(2001)308:963-973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11352585?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the second PDZ domain of NHERF-1</PDB_Title>
      <PDB_ID>2JXO</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JXO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Autoinhibitory Interactions between the PDZ2 and C-terminal Domains in the Scaffolding Protein NHERF1</PubMed_Title>
      <Author>Cheng, H., et al.</Author>
      <Journal>Structure(2009)17:660-669</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19446522?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the Radixin FERM domain complexed with the NHERF-1 C-terminal tail peptide</PDB_Title>
      <PDB_ID>2D10</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2D10</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for NHERF recognition by ERM proteins</PubMed_Title>
      <Author>Terawaki, S., et al.</Author>
      <Journal>Structure(2006)14:777-789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16615918?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of extended PDZ2 domain from NHERF1 (150-270)</PDB_Title>
      <PDB_ID>2KJD</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2KJD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A dynamic intramolecular conformational switch autoregulates the scaffolding protein NHERF1</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Solution Structure of human sodium/ hydrogen exchange regulatory factor 1(150-358)</PDB_Title>
      <PDB_ID>2KRG</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2KRG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A conformational switch in the sodium/ hydrogen exchange regulatory factor 1(NHERF1) controls autoinhibition and complex formation.</PubMed_Title>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.ge.b.b.bd.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1g9o</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Allosteric switch</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>